Ra Capital Management, L.P. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $4.58 Billion distributed in 64 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.77B, Vaxcyte, Inc. with a value of $389M, Rhythm Pharmaceuticals, Inc. with a value of $351M, Janux Therapeutics, Inc. with a value of $258M, and Avidity Biosciences, Inc. with a value of $206M.
Examining the 13F form we can see an decrease of $240M in the current position value, from $4.82B to 4.58B.
Ra Capital Management, L.P. is based out at Boston, MA
Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.
